• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

CLIA - Clinical Laboratory Improvement Amendments

  • Print
  • Share
  • E-mail
-
1 to 10 of 12 Results
Document Number K032564
 
 1 
 2 
 > 
Results per Page

New Searchexport reports to excelExport to Excel | HelpHelp
Document Parent Analyte Analyte Specialty Complexity Effective Date
Siemens Healthcare Diagnostics Inc. Atellica CH Analyzer  
CR190007 K032564 N-acetylprocainamide (NAPA) Toxicology / TDM MODERATE 02/20/2019
Siemens Dimension EXL 200  
K073604 K032564 N-acetylprocainamide (NAPA) Toxicology / TDM MODERATE 08/16/2011
Siemens Dimension RxL Max  
K010061 K032564 N-acetylprocainamide (NAPA) Toxicology / TDM MODERATE 06/20/2011
Siemens Dimension Xpand  
K010061 K032564 N-acetylprocainamide (NAPA) Toxicology / TDM MODERATE 06/20/2011
Siemens Dimension Xpand Plus  
K010061 K032564 N-acetylprocainamide (NAPA) Toxicology / TDM MODERATE 06/20/2011
Siemens Dimension RxL  
K010061 K032564 N-acetylprocainamide (NAPA) Toxicology / TDM MODERATE 06/20/2011
Siemens Dimension EXL with LM System  
K073604 K032564 N-acetylprocainamide (NAPA) Toxicology / TDM MODERATE 07/08/2009
Dade Behring Dimension RxL Max  
K032564 K032564 N-acetylprocainamide (NAPA) Toxicology / TDM MODERATE 11/10/2003
Dade Behring Dimension RxL  
K032564 K032564 N-acetylprocainamide (NAPA) Toxicology / TDM MODERATE 11/10/2003
Dade Behring Dimension Xpand  
K032564 K032564 N-acetylprocainamide (NAPA) Toxicology / TDM MODERATE 11/10/2003

-
-